Sumagang, Aneliva S.
HRN: 04-31-21 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2022
CEFTAZIDIME 1GM (VIAL)
12/23/2022
12/30/2022
IV
1 Gram
Q8
Complicated UTI
Waiting Final Action